Why This Matters to You
Imagine relying on a trusted antibiotic to treat an infection, only to find out it’s fake. That’s exactly what happened recently in Lagos when the National Agency for Food and Drug Administration and Control (NAFDAC) discovered a counterfeit batch of Tarivid — a widely used antibiotic containing Ofloxacin. This discovery sparked a nationwide alert that exposed a troubling undercurrent in Nigeria’s pharmaceutical landscape: the pervasive risk of counterfeit medicines.
This article takes you deep into the heart of this alert—breaking down what counterfeit Tarivid means for your health, why it happened, how NAFDAC responded, and what you can do to protect yourself. If you or anyone you know relies on antibiotics, this information is crucial. Let’s walk through it step-by-step.
Understanding Tarivid: What Is It and Why Is It Important?
Tarivid is a brand name for the antibiotic drug Ofloxacin, which belongs to a class of medications known as fluoroquinolones. It is commonly prescribed to treat bacterial infections including respiratory tract infections, urinary tract infections, skin infections, and certain sexually transmitted diseases.
Ofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial replication. This action halts bacterial growth and helps clear infections. Given its effectiveness, Tarivid is widely trusted in Nigeria and globally as a go-to antibiotic.
Because bacterial infections are common and sometimes serious, having access to effective antibiotics like Tarivid is critical. When the quality or authenticity of such a drug is compromised, the consequences can be dire.
What Is Counterfeit Medication?
Counterfeit medications are fake drugs that may appear legitimate but are produced and sold illegally. They often contain incorrect ingredients, wrong doses, or harmful substances. Sometimes, they contain no active ingredients at all.
In the context of pharmaceuticals, counterfeits are dangerous because:
They can cause treatment failures.
They may provoke adverse side effects or poisoning.
They contribute to antimicrobial resistance by exposing bacteria to subtherapeutic doses.
They undermine public trust in healthcare.
nafdac.gov.ng
telegraph.ng
Counterfeit medicines are a global problem, but developing countries like Nigeria face heightened risks due to weak regulatory enforcement and porous supply chains. The presence of counterfeit Tarivid in Lagos highlights these vulnerabilities in stark terms.
Details of the Counterfeit Batch
Let’s unpack what makes this Tarivid batch such a serious concern:
The exact product flagged by NAFDAC was Tarivid (Ofloxacin 200 mg tablets) labeled as manufactured by Sanofi-Aventis Pakistan Limited.
This batch was found during routine post-market surveillance conducted in Lagos.
The packaging bore a NAFDAC registration number (AL016), which gave the impression of legitimacy; however, this batch was not registered for the Nigerian market.
Sanofi confirmed the batch was intended only for Pakistan, indicating it had been illicitly diverted and introduced into the Nigerian market.
The discovery took place in Lagos State, particularly around central drug distribution points.
This counterfeit product is not a mere labeling error; it’s a deliberate and illegal diversion exploiting supply chains, designed to deceive consumers and health professionals.
This mix of authentic-looking packaging combined with illicit origin is dangerous. It confuses consumers into trusting a product that could be ineffective or harmful.
Health & Regulatory Risks
Encountering a counterfeit antibiotic like Tarivid is more than just a packaging problem — it’s a direct threat to your health and the healthcare system.
Unpredictable Composition
Counterfeit medicines can have incorrect or inconsistent levels of active ingredients. They may contain no active ingredient, or even harmful contaminants. This unpredictability risks treatment failure and exposes patients to unknown dangers.
Treatment Ineffectiveness and Resistance
Taking a fake antibiotic means your infection might not be treated properly. Worse, subtherapeutic doses can enable bacteria to survive and develop resistance. This not only threatens the individual patient but also accelerates the global health crisis of antimicrobial resistance.
Direct Harm from Unknown Ingredients
Counterfeit drugs may contain toxic substances or contaminants, risking allergic reactions, organ damage, or poisoning. Consumers have no way of knowing what they are ingesting, making counterfeit drugs a hidden health hazard.
Regulatory Oversight Breached
NAFDAC clearly stated that the counterfeit Tarivid batch was not registered in Nigeria, meaning its safety and efficacy are unverified. This breach in regulatory controls compromises patient safety and undermines the credibility of Nigeria’s drug approval system.
Broader Threat to Nigeria’s Healthcare System
The presence of diverted products meant for other countries circulating illegally within Nigeria signals weak control in pharmaceutical importation and distribution. It erodes trust among healthcare providers and patients, threatening the entire healthcare delivery system.
guardian.ng
+1
thenationonlineng.net
+1
NAFDAC’s Response Actions
NAFDAC acted swiftly and decisively upon discovering the counterfeit Tarivid batch.
Immediate Public Warning
On June 10, 2025, NAFDAC issued a public alert naming the counterfeit product and describing its packaging and origin. The agency also communicated this to international bodies to trigger global vigilance.
Enforcement Across Distribution Channels
NAFDAC’s Post-Marketing Surveillance Directorate conducted inspections targeting major pharmaceutical distribution hubs, pharmacies, wholesalers, and hospitals nationwide. Their goal was to remove all stocks of the counterfeit batch to prevent further circulation.
Strengthening Regulatory Enforcement
This alert fits within a broader campaign intensified since early 2025, where thousands of outlets selling counterfeit drugs have been shut down, and large quantities of fake medicines seized across multiple Nigerian states.
Call for Vigilance
NAFDAC urged healthcare providers, pharmacists, and the public to carefully inspect medicines, verify registration numbers, and report suspicious products. Consumers were encouraged to use authentication tools like NAFDAC’s Mobile Authentication Service.
Stronger Penalties for Offenders
NAFDAC’s leadership emphasized ongoing legal actions, including arrests and prosecutions, to deter counterfeiters and hold violators accountable.
Ongoing Surveillance and Collaboration
This incident is part of NAFDAC’s National Action Plan (2023–2027) to eliminate fake drugs through enhanced monitoring, partnerships with security agencies, and international collaboration with the World Health Organization and others.
Context: Counterfeit Medicines in Nigeria
The counterfeit Tarivid case is not isolated but part of a widespread crisis in Nigeria’s drug market.
Scope of the Problem
Reports indicate that roughly 70% of drugs in Nigeria may be substandard or counterfeit, with nearly 41% being counterfeit and 14.7% outright fake. These figures reflect the enormous challenge facing regulators and consumers alike.
Contributing Factors
Multiple factors fuel counterfeit drug proliferation:
Limited regulatory capacity and enforcement reach.
High demand for affordable medications, pushing consumers toward cheaper, potentially fake products.
Low public awareness about how to identify genuine drugs.
Corruption and illicit trade networks facilitating illegal importation and distribution.
Health Implications
The consequences include treatment failure, adverse effects, and accelerating antimicrobial resistance—all of which endanger public health and strain healthcare resources.
NAFDAC’s Efforts
NAFDAC has increased surveillance, public awareness, and enforcement efforts. International cooperation and public education remain critical pillars in this fight.
Path Forward
To curb counterfeit drugs, Nigeria must invest in stronger regulatory systems, broaden public education, engage communities, and deepen international partnerships.
How to Identify and Avoid Counterfeit Tarivid
Your health depends on being able to spot fake medicines. Here are practical tips to protect yourself:
Identifying Genuine Tarivid
-
Packaging is clean, professional, and features the Sanofi logo and NAFDAC registration number AL016.
-
Tablets are round, white, and scored for splitting.
-
Manufacturing and expiry dates are clearly printed and legible.
Spotting Counterfeit Versions
-
Look for misspelled words, inconsistent fonts, or poor-quality printing.
-
Check tablets for size, shape, or color differences.
-
Avoid products missing batch numbers or expiry dates.
Steps If You Suspect Counterfeit Drugs
-
Do not consume the product.
-
Report immediately to NAFDAC via their official communication channels.
-
Consult a healthcare professional promptly.
Educating Yourself and Others
-
Share knowledge about counterfeit drug risks with family and friends.
-
Use NAFDAC’s authentication services to verify medicines.
-
Stay updated on alerts from regulatory agencies.
The Urgency of Vigilance
The discovery of counterfeit Tarivid in Lagos highlights an ongoing public health threat that demands our attention. Fake medicines jeopardize individual treatment outcomes and weaken Nigeria’s healthcare system. This alert reminds us that vigilance is essential—not only from regulators but also from healthcare professionals and consumers.
Stay informed, scrutinize your medications carefully, and report suspicious products. Support regulatory agencies as they work tirelessly to protect public health. Together, through awareness, enforcement, and education, we can reduce the dangers posed by counterfeit medicines and ensure safe, effective treatment for all Nigerians.
Your health is worth the extra caution.
